SightfileU.S. market data from official filings

Companies › INNV

INNOVAGE HLDG CORP (INNV)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001834376 · EDGAR filings · Updated 2026-07-27

INNOVAGE HLDG CORP (INNV) has reported institutional ownership of 11.8%, with 102 institutional managers holding positions valued at $128.0M per the latest 13F reporting period.

Institutional ownership
11.8%
Institutional managers
102
Reported 13F value
$128.0M
Insider activity
30 trans.
$159.1K net buying

Filings this week (4)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, INNOVAGE HLDG CORP has 102 institutional holders and institutional ownership of 11.8%.

Insider activity

Insiders reported 30 transactions (11 buys, 1 sells) across 10 reporting insiders, with a net reported value of $159.1K.

Related companies

INFUSYSTEM HLDGS INC (INFU) · VOYAGER THERAPEUTICS INC (VYGR) · QUANTERIX CORP (QTRX) · EDITAS MEDICINE INC (EDIT) · HERON THERAPEUTICS INC (HRTX) · MACROGENICS INC (MGNX)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-27.